Epidermal differentiation complex genetic variation in atopic dermatitis and peanut allergy

Area of Science:

• Genetics
• Dermatology
• Allergy Immunology

Background:

• Deleterious genetic variations in the epidermal differentiation complex (EDC) on chromosome 1 are established risk factors for atopic dermatitis (AD).
• Population studies suggest a link between EDC variations and peanut allergy (PA) risk.

Purpose of the Study:

• To investigate the impact of genetic variation within the EDC on the progression of AD.
• To determine the association between EDC genetic variations and the risk of developing PA in early childhood.

Main Methods:

• Genome sequencing was employed to identify deleterious genetic variations in the EDC among participants of the Learning Early about Peanut Allergy (LEAP) study.
• Association analyses were conducted to link gene and variant-level predicted deleterious variations with AD severity (SCORAD tool) and PA risk.
• Statistical models (linear and generalized linear regression) were used to test associations between variant load, AD severity, and PA.

Main Results:

• The FLG gene exhibited the highest number of predicted deleterious variations, followed by FLG2, HRNR, and TCHH1.
• FLG variants were significantly associated with SCORAD scores at all study time points, with higher variant load correlating with increased AD severity over time.
• A significant association was found between specific FLG variants and PA, independent of baseline AD severity (OR = 2.63).

Conclusions:

• Deleterious variations in the FLG gene are strongly associated with both the severity of AD and the risk of developing PA.
• The findings highlight FLG as a key genetic determinant influencing the trajectory of AD and the development of PA in early life.